Table 6 Laboratory parameters at baseline and post-[177Lu]Lu-DOTA-ZOL treatment
Parameters | Patients receiving single cycle | Patients receiving 2 cycles | ||||
|---|---|---|---|---|---|---|
Baseline (median, IQR) | Post-treatment (median, IQR) | P value | Baseline (median, IQR) | Post-treatment (median, IQR) | P value | |
Haemoglobin (g/dL) | 10.2 (9.6–10.6) | 10 (8.9–11) | 0.129 | 14.7 (10–12.4) | 13 (9.2–11) | < 0.0001 |
Platelets (lakhs/µL) | 172 (140.2–198) | 143 (129.2–198.5) | 0.039 | 223 (164–284.25) | 217 (170–275.5) | 0.421 |
Leukocytes 109/L | 6760 (4210–11,800) | 5400 (3700–10,800 | 0.291 | 6700 (4280–12,000) | 5400 (3800–10,900) | 0.298 |
Creatinine (mg/dL) | 0.8 (0.63–0.96) | 0.79 (0.6–0.94) | 0.259 | 0.7 (0.7–0.9) | 0.8 (0.7–0.8) | 0.174 |
ALP (IU/L) | 282 (190–480) | 189 (140–280) | 0.0001 | 278 (186–390) | 230 (142–340) | 0.003 |